Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management

BACKGROUND: Drug-induced colitis is a known complication of therapies that alter the immune balance, damage the intestinal barrier or disturb intestinal microbiota. Immune checkpoint inhibitors (ICI) directed against cancer cells may result in activated T lymphocyte-induced immune-related adverse ev...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Therap Adv Gastroenterol
Glavni autori: Shivaji, Uday N., Jeffery, Louisa, Gui, Xianyong, Smith, Samuel C. L., Ahmad, Omer F., Akbar, Ayesha, Ghosh, Subrata, Iacucci, Marietta
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2019
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6831976/
https://ncbi.nlm.nih.gov/pubmed/31723355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284819884196
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items